Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxinning Tablet Phase II Trial in ASCVD Patients With Vulnerable Carotid Plaques
CTR20254709Phase 2Active
- Sponsor
- Chia Tai Qingchunbao
- Start
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Guanxinning in atherosclerotic disease, Carotid artery disease (CAD), sponsored by Chia Tai Qingchunbao. Started Jun 2026; status: active.
02
Drugs
Guanxinning
03
Conditions
atherosclerotic diseaseCarotid artery disease (CAD)
Beyond the preview
Go deeper on CTR20254709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254709.